Status:

COMPLETED

Health Economic Evaluation of Primovist-enhanced Liver MRI

Lead Sponsor:

Bayer

Conditions:

Colorectal Neoplasms

Neoplasm Metastasis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Patients with a history of colorectal cancer and known or suspected liver metastases who are scheduled for contrast-enhanced tomographic imaging will be included in this study. After randomization to ...

Eligibility Criteria

Inclusion

  • Patients with known or suspected metachronous liver metastases secondary to colorectal cancer who are scheduled for further contrast-enhanced tomographic imaging

Exclusion

  • Patients (men or women) under 18 years of age
  • Patients who have received any contrast material within 24 hours before injection of study drug, or who are scheduled to receive any contrast material within 24 hours after injection
  • Patients not eligible to contrast media (CM) injection according to product labeling
  • Women who are pregnant, lactating or who are of childbearing potential and have not had a negative urine pregnancy test at baseline visit(s)
  • Patients scheduled for liver-specific MRI other than Primovist-enhanced MRI, i.e. Multihance-, Teslascan- or SPIO-enhanced MRI
  • Patients who are clinically unstable and whose clinical course is unpredictable (e.g. due to previous surgery, acute myocardial infarction)
  • Patients with known anaphylactoid or anaphylactic reaction to any contrast media or hypersensitivity to any allergen including drugs
  • Patients with a contraindication for MRI or CT.
  • Patients with severe renal impairment (eGFR \< 30ml/min/1.73m2) or patients on dialysis

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2010

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT00764621

Start Date

October 1 2008

End Date

November 1 2010

Last Update

November 4 2014

Active Locations (44)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 11 (44 locations)

1

Vienna, Vienna, Austria, 1090

2

Graz, Austria, 8036

3

Vienna, Austria, 1030

4

Karlsruhe, Baden-Wurttemberg, Germany, 76133

Health Economic Evaluation of Primovist-enhanced Liver MRI | DecenTrialz